Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: Incidence, mortality and clinical characterization

Because of the potentially high mortality rate (6.5%) associated with bortezomib-induced lung disease (BILD) in Japanese patients with relapsed or refractory multiple myeloma, we evaluated the incidence, mortality and clinical features of BILD in a Japanese population. This study was conducted under...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshizawa, Kazutake, Mukai, Harumi Y, Miyazawa, Michiko, Miyao, Makiko, Ogawa, Yoshimasa, Ohyashiki, Kazuma, Katoh, Takao, Kusumoto, Masahiko, Gemma, Akihiko, Sakai, Fumikazu, Sugiyama, Yukihiko, Hatake, Kiyohiko, Fukuda, Yuh, Kudoh, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317820/
https://www.ncbi.nlm.nih.gov/pubmed/24329927
http://dx.doi.org/10.1111/cas.12335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317820/
https://www.ncbi.nlm.nih.gov/pubmed/24329927
http://dx.doi.org/10.1111/cas.12335

Ejemplares similares